✦ LIBER ✦

PCV126 THE CARDIOVASCULAR CONSEQUENCES OF SWITCHING FROM ATORVASTATIN TO GENERIC SIMVASTATIN IN THE NETHERLANDS

✍ Scribed by D Liew; K Webb; WJ Meerding

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Potential cardiovascular consequences of

✍ D. Liew, K. Webb, W.-J. Meerding, E. Buskens, J. W. Jukema 📂 Article 📅 2012 🏛 Bohn Stafleu van Loghum 🌐 English ⚖ 121 KB

PCV92 THE HEALTH AND ECONOMIC IMPACT OF

✍ D Liew; K Webb; S Marbaix 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PCV72 COST-EFFECTIVENESS OF ATORVASTATIN

✍ JL Severens; MH Prins; HC Monteban 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

PCV92 THE HEALTH AND ECONOMIC IMPACT OF

✍ D Liew; A Kuznik; K Webb; CS Roberts 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

PMH29 SWITCHING FROM BRANDED TO GENERIC

✍ F Van Nooten; C Rijnders; R Brown; M Van Agthoven 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

PCV6 A META-ANALYSIS OF EFFICACY OF ATOR

✍ MA Villasis-Keever; ME Rendón-Masías; R Pineda-Cruz; A Escamilla-Nuñez; JF Mould 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB